Recombinant adenovirus vectors have provided a major advance in gene delivery systems for post-mitotic neurons. However, the use of these first generation vectors has been limited due to the onset of virally mediated effects on cellular function and viability. In the present study we have used primary cultures of cerebellar granule neurons to examine the efficacy and cytotoxic effects of a helper-dependent adenovirus vector (hdAd) in comparison with a first generation vector. Our results demonstrate that the hdAd system provides equally efficient infectivity with significantly reduced toxicity in comparison to first generation vectors. Neurons transduced with a high titre of a first generation vector exhibited a time-dependent shut down in global protein synthesis and impaired physiological function as demonstrated by a
Introduction
The delivery of transgenes to postmitotic neurons has been a notoriously difficult task, particularly because neurons are not readily transfected by traditional protocols and MoLV-based retroviral vectors are unable to integrate into their genome. Furthermore, microinjection techniques are relatively labour intensive and can only target a small proportion of the population. Over the past 5 years replication-defective DNA viruses as expression systems for postmitotic neurons have been of great interest. In particular, recombinant adenovirus vectors (Ads) have shown promise as the vector of choice for gene delivery to neurons with the advantages of: (1) the ease of genetic manipulation; (2) their ability to transduce most tissues including terminally differentiated cells; (3) purification to high titres; and (4) their relative safety. [1] [2] [3] First generation vectors in which the expression cassette replaces the E1 region are replication-defective and have been shown to efficiently transduce neuronal cells in vitro and in vivo. [4] [5] [6] Since then Ads have been used as reagents to dissect molecular pathways in neurons [7] [8] [9] as well as for loss of glutamate receptor responsiveness. This was followed by an increase in the fraction of TUNEL-positive cells and a loss of neuronal survival. In contrast, hdAds could be used at titres that transduce Ͼ85% of neurons with little cytotoxic effect: cellular glutamate receptor responses and rates of protein synthesis were indistinguishable from uninfected controls. Furthermore, cell viability was not significantly affected for at least 7 days after infection. At excessive viral titres, however, infection with hdAd did cause moderate but significant changes in cell function and viability in primary neuronal cultures. Thus, while these vectors are remarkably improved over first generation vectors, these also have limitations with respect to viral effects on cellular function and viability. Gene Therapy (2000) 7, 1200-1209.
the development of neuroprotective strategies following neuronal injury. 10 While Ads have shown great promise, detailed studies examining vector effects on neuronal physiology have brought to light some concerns regarding these reagents. In vivo injection into many different tissues has revealed immunogenic responses leading to the loss of gene expression within 4-6 weeks of delivery. [11] [12] [13] [14] Furthermore, in vitro experiments have also identified important limitations with the use of these vectors. 2, 15 First, titres must be carefully controlled because excessive levels result in nuclear degeneration followed by loss of viability. 2 If minimal titres are used, expressing cells will appear normal. Five days after infection, however, cells exhibit stress protein responses and a shut down of total cellular protein synthesis. 15 Thus, in vitro studies utilizing first generation Ad vectors must be rigorously controlled by: (1) minimizing viral titre, and (2) limiting usage to short-term studies, within 4 days following vector delivery to avoid complications due to global protein synthesis shut down.
The cause of adverse cellular effects of Ads in vitro could be attributed to a number of factors including cytotoxic effects arising from the virion itself 14, 16, 17 and toxicity due to low level viral gene expression from the vector backbone. 18, 19 Cellular transcription factors such as E2F can co-operate with viral proteins such as E4 to acti-vate viral genes. 20, 21 To minimize chronic viral gene expression second generation Ad vectors have been generated with deletions in E2 and E4. However, propagation of these vectors is complicated by the further requirement for E2 and E4 protein expression in the complementing host cells, and improved tolerance has not yet been demonstrated. [22] [23] [24] [25] [26] [27] [28] [29] Recently, a system has been developed for the production of helper-dependent Ad vectors (hdAd) that are deleted for most adenovirus coding sequences. 30 In this system, the helper virus contains a packaging signal flanked by loxP sites. Following infection of a 293 cell line stably expressing the bacteriophage P1 Cre recombinase, 31, 32 the packaging signal is excised thereby preventing packaging of the helper virus genome. Thus, the helper virus can provide in trans all replication and packaging functions required for the hdAd. This newly developed vector system can produce relatively high titres of hdAd with minimal contamination from helper virus. The major advantage of this type of vector is that the vector DNA is deleted of all Ad coding sequences thereby minimizing chronic toxicity believed to be associated with low level viral gene expression. Studies delivering the ␣-antitrypsin gene using hdAds in vitro and in vivo have shown that these fully deleted Ad vectors can provide high-level, longterm gene expression, consistent with improved tolerance due to the absence of the viral genome. 33 Although Ad vectors represent a major advance for gene delivery to postmitotic neurons, their cytotoxic effects have seriously limited their potential. In the present study we have used primary cultures of cerebellar granule neurons to examine the efficacy and cytotoxic effects of hdAd in comparison to first generation Ads. Our results show that the hdAd system provides equally efficient infectivity with limited toxicity in comparison to first generation vectors. However, excessively high titres did, nevertheless, exhibit adverse physiological effects. Unlike first generation vectors, however, concentrations that provide 100% infectivity can now be used without perturbing neuronal physiology or suppressing cellular protein synthesis. Thus, hdAds have overcome the major obstacles associated with the use of first generation vectors and thereby provide an efficient reliable gene delivery system for postmitotic neurons.
Results

Helper-dependent adenovirus vectors efficiently transduce neurons in vitro
We first asked whether helper-dependent adenovirus vectors were as efficient a gene delivery system as the first generation Ad vectors. Both vectors contained identical expression cassettes consisting of a murine CMV promoter driving the lacZ reporter gene. The viruses were titred for blue forming units (b.f.u.) as well as particle content, to determine whether there was any correlation between cytotoxicity and particle content. The particle content per b.f.u. was slightly higher for the hdAd at 26 particles/b.f.u. in comparison to the first generation vector that contained 14 particles/b.f.u. The level of helper virus contamination of the hdAd preparation was estimated at 1 plaque forming unit (p.f.u.) per 10 5 b.f.u. Adenovirus stocks used were tested for replicationcompetent adenovirus contamination using the Hela cell Gene Therapy cytotoxicity assay and were all found to be less than one in 10 9 p.f.u. Cerebellar granule neurons were infected at equal titres of each vector ranging from 0.25 × 10 7 to 8 × 10 7 b.f.u./ml (Figure 1 ). At 0.25 × 10 7 b.f.u./ml about 28 ± 11% of cells in cultures infected with AdCA35 were ␤-gal positive relative to 36 ± 7% of cells in cultures treated with hdAd. At 1 × 10 7 b.f.u./ml the number of transduced cells plateaued with both vectors, such that the majority of cells were expressing ␤-galactosidase, 87 ± 5% for AdCA35 and 89 ± 4% for hdAd. At 2 × 10 7 b.f.u./ml cells transduced with either vector appeared healthy exhibiting round cell bodies and intact neuritic processes at 72 h after infection (Figure 1b) . Thus, hdAd is as efficient as first generation vectors with respect to infectivity.
Physiological response of hdAd is markedly improved over first generation vectors Due to the adverse effects previously reported with first generation vectors 2, 15 we asked whether hdAds were improved with respect to cytotoxicity in neuronal cells. In the following experiments neuronal physiology was assessed at the viral titres, 2 × 10 7 ; 4 × 10 7 and 8 × 10 7 b.f.u./ml, which is equivalent to 25, 50 and 100 MOI, respectively. The lower titre of 2 × 10 7 b.f.u./ml represents a typical working dilution as determined for transduction of primary cerebellar granule neurons because it yields greater than 85% ␤-gal expressing cells. Two-and four-fold higher concentrations, however, were also used to determine the limitations in the use of the hdAd as a gene delivery system for neuronal cells. As cerebellar granule neurons contain functional glutamate receptors we assessed their ability to respond to glutamate receptor agonists by measurement of increased trations tested. It should be noted, however, that at higher titres of hdAds there was a detectable decrease in the magnitude of [Ca 2+ ] i response with all three agonists tested, indicating that even fully deleted vectors had some toxic effects on the neuronal physiology when used at excessive titres.
Cellular protein synthesis remains active in neurons transduced by hdAds
Previous studies have demonstrated a decrease in global protein synthesis in response to viral infection. 34, 35 Specifically, studies designed to examine cytotoxic affects of first generation Ads have reported a dramatic decrease in cellular protein synthesis 5 days following vector delivery. 15 Since the low levels of chronic viral gene expression are believed to be one of the causes of protein synthesis arrest, the fully deleted vector would be expected to resolve this issue. To compare the effects of first generation and helper-dependent vectors on cellular protein synthesis, cells were infected at two concentrations, 2 × 10 7 b.f.u./ml as a typical working concentration at which greater than 89% of cells are transduced; and a higher concentration of 8 × 10 7 b.f.u./ml to test whether there are any limitations to the use of hdAds. Cells were infected at the time of plating and protein synthesis was measured during a time-course of up to 7 days, at which point first generation vectors have been shown to impair cellular protein synthesis seriously. 15 At the lowest viral titre (Figure 4a ) AdCA35 infected neurons exhibited a protein synthesis rate of 70 ± 10% of control by day 5 post-infection, while neurons transduced with hdAd were indistinguishable from controls. By day 7, however, a dramatic decline of cellular protein synthesis to 23 ± 7% was apparent with AdCA35 while cells transduced with hdAd were not affected (Figure 4a ). Thus at a typical working titre, first generation vectors can be used for up to 5 days, after which time a dramatic impairment in cellular function occurs. In contrast, hdAd vectors did not perturb cellular protein synthesis when used at a typical working concentration of 2 × 10 7 b.f.u./ml. To determine if higher concentrations of hdAd impaired cellular physiology, neurons were exposed to a four-fold higher titre. Consistent with previous reports, first generation vectors induced a dramatic inhibition of cellular protein synthesis that became apparent as early as day 3 at which point protein synthesis rates were 37 ± 4% of control and continued to decline to 6 ± 4% by day 7. In contrast, cells transduced with hdAds were not significantly different from control cells at days 2 and 3 but showed a significant decline in protein synthesis (53 ± 1% and 63 ± 8% by days 5 and 7) (Figure 4b ). In summary, first generation vectors caused a dramatic decrease in global protein synthesis by 7 days after infection even at the lowest titre examined and are therefore limited in their utility with respect to viral titre and time. In contrast, hdAds exhibited no detectable perturbation when used at a typical working concentration of 2 × 10 7 b.f.u./ml. While cytotoxicity caused by hdAds was remarkably reduced in comparison to AdCA35, higher titres caused a significant decline in protein synthesis that was apparent by 5 days after infection. These experiments demonstrate that while these vectors are significantly improved over first generation vectors, there are limitations with respect to viral effects on cellular function. 
Survival of cells transduced with hdAds versus first generation Ads
As a decrease in total cellular protein synthesis became evident when hdAds were used at higher titres, we asked whether neuronal survival was significantly affected by this vector. Cells were infected with AdCA35 and hdAds at titres of 2, 4 and 8 × 10 7 b.f.u./ml and cell survival was assayed by assessing mitochondrial function by MTT assay. At the lowest titre there was a slight decrease in the viability of cells transduced with AdCA35 of 70 ± 9% of control whereas no significant change in cell survival was found with hdAds at either 2 or 4 × 10 7 b.f.u./ml. At a titre of 4 × 10 7 b.f.u./ml again, cells transduced with AdCA35 exhibited good viability up until day 5 after which a dramatic decrease to 30.7 ± 10% of control was evident. At a titre of 8 × 10 7 b.f.u./ml AdCA35 exhibited severe cytotoxic effects resulting in cell survival of only 38 ± 11% of control at day 5 and 16 ± 6% 7 days after infection (Figure 5c ). When used at a similarly high concentration (8 × 10 7 b.f.u./ml) hdAds induced only a slight although statistically (P Ͻ 0.05) significant decrease in cell survival with no effect up to 5 days and a decline in viability to 65 ± 12% by day 7, a pattern reminiscent of AdCA35 at the lowest concentration. Consistent with these minimal effects on cell viability, morphological examination of neurons following transduction with hdAds ( Figure 6c) showed intact processes and round healthy cell bodies that were similar to uninfected controls (Figure 6a ). In contrast, cells infected at identical titres with AdCA35 (8 × 10 7 b.f.u./ml) revealed shrunken cell bodies and degenerating neuritic processes by 7 days after infection (Figure 6b) .
It has been previously suggested that the lacZ gene may contribute to the toxicity caused by first generation vectors. 36 To determine whether the toxicity of first generation Ads results, at least in part, from the expression of high levels of the lacZ gene, the cytotoxicty of first generation vectors carrying the lacZ (AdCA35), an empty E1-deleted vector (AdCMV), and the helper-dependent vector (AdRP1050) was compared. Our results indicate that the levels of toxicity caused by the lacZ expressing vector were similar to that of the empty vector. Specifically, at 8 × 10 7 p.f.u./ml, AdCA35 exhibited 26 ± 2% survival after 5 days (n = 3), AdCMV exhibited 39 ± 6% survival (n = 3), and hdAdRP1050 resulted in 76 ± 8% survival after 5 days (n = 3). These studies indicate that the toxicity induced by first generation vectors results primarily from the vector itself rather than lacZ gene overexpression, consistent with results reported previously by Easton et al. 15 To determine whether cells infected with hdAds exhibited signs of apoptosis, neurons were stained by TUNEL at 7 days following transduction at 2, 4 and 8 × 10 .f.u./ml with hdAds did not exhibit a significant increase over controls (Figure 7b ). In contrast, cells transduced with AdCA35 exhibited 45 ± 5% TUNEL-positive cells 7 days following infection at 4 × 10 7 b.f.u./ml. At the highest titre of hdAds a significant increase of 30 ± 3% was found indicating that the fully deleted vector can cause neuronal cell death when used at the highest concentration. It should be noted, however, that this is a remarkable improvement over the first generation that induced apoptosis in 75 ± 5% of neurons when used under identical conditions (Figure 7b ).
In summary, first generation vectors are limited in their utility with respect to gene delivery to neuronal cells because of cytotoxic effects manifested by impaired physiological function, protein synthesis shut down, and loss of viability through apoptosis. This limits the use of these vectors primarily to in vitro experiments in which 
u./ml and an MTT survival assay was conducted at 3, 4, 5 and 7 days after infection. Control, uninfected cells were considered 100% and the results are reported as the percentage of control. Data represent the mean of three separate experiments with error bars showing s.d.
Figure 6 hdAd infected CGNs exhibit improved viability. Phase-contrast photomicrographs of CGNs uninfected (A), infected with AdCA35 (B), or hdAd (C) at 8 × 10
7 b.f.u./ml 7 days after infection. Scale bar, 20 m.
titres must be rigorously minimized and experiments can be relatively short term (5 days). In contrast, hdAds can be used at titres that transduce 85% of cells with little cytotoxic effect. Specifically, at 2 and 4 × 10 7 b.f.u./ml cellular glutamate receptors respond normally, total cellular protein synthesis and cell viability is indistinguishable from control for at least 7 days after infec- 
Discussion
The results of these studies support a number of conclusions. First, infectivity comparisons show that hdAds are as efficient as first generation vectors for delivering genes to postmitotic neurons. Second, cells treated with hdAds exhibit remarkably fewer cytotoxic effects in comparison with cells transduced by first generation vectors. These results suggest that a major contributing factor to neuronal pathology associated with adenovirusmediated gene delivery results from the retention of most of the viral genome. Finally, although fully deleted vectors are relatively well tolerated by neurons, their use at high titres can lead to significant impairment of cell function.
The use of Ad vectors as gene delivery agents to postmitotic neurons represents an important step forward as mechanistic studies in the past have been confounded by the inherent difficulties in transgene delivery to this cell type. While first generation vectors may provide useful tools for short-term studies in vitro, longer term experiments or in vivo experiments are complicated by the cytotoxic and immunogenic effects of first generation vectors. 2 Despite the absence of immunogenic responses in vitro, studies have provided compelling evidence that first generation vectors can cause damage to neuronal cells. Higher titres have been shown to lead to nuclear degeneration and apoptosis, 7 while lower concentrations can cause up-regulation of stress protein responses and a dramatic decrease in global protein synthesis 5 days after infection (Figure 4) . 15 There are several factors that could contribute to these adverse affects. The viral coat proteins themselves may cause toxicity, 37 however, this type of effect would be expected to become evident immediately following infection. The most likely cause of toxicity is the chronic transcription of viral DNA despite the absence of E1. It is thought that toxicity caused by such genes may be through interaction with cellular proteins such as E2F, thereby impairing their function. In fact, E2F-dependent genes were aberrantly induced in neurons transduced with first generation Ads. 15 Thus, it is believed that the low-level transcription of the viral genome despite the deletion of E1, is one of the major causes of cytotoxicity with Ad vectors.
To circumvent vector-mediated cytotoxicity several new types of vectors have been developed including those with deletions in regions E2 or E4 24, 26, 27, 29, 38 and helper-dependent Ads. 30, [39] [40] [41] [42] [43] To minimize difficulties associated with contaminating helper virus, a Cre/loxP helper-dependent system was developed. 30 These newly developed vectors have been tested in vivo in liver tissue and virally mediated expression of the ␣1-antitrypsin gene was maintained for up to 1 year. 33, 44, 45 As previous studies implicated viral gene expression as an underlying cause in viral toxicity in neurons, we examined the effect of helper-dependent Ads on primary neurons. If lowlevel viral gene expression is indeed the cause of cytotoxicity in neurons, then helper-dependent Ad vectors would be expected to resolve these difficulties.
The studies reported here demonstrate that hdAds exhibit a remarkable improvement in vector-mediated cytotoxic effect in neurons. While lower titres of first generation vectors (2 × 10 7 b.f.u./ml) lead to global protein synthesis shut down and loss of viability evident at 7 days after infection, cells transduced with hdAds did not exhibit any cytotoxic effects. In comparison, a four-fold higher titre of AdCA35 led to impaired glutamate triggered [Ca 2+ ] i responses and protein synthesis shut down occurring as early as day 3 in vitro. While there was no apparent morphological change in cells treated under identical conditions with hdAd, examination of cellular function consistently revealed viral effects. At 8 × 10 7 b.f.u./ml, neurons appeared healthy and no change in viability was detectable at 5 days after infection. However, at this time a decreased response to glutamate receptor agonists was consistently evident (Figures 2 and  3 ) and global protein synthesis (Figure 4b ) was reduced to 63 ± 8% of control. The improved tolerance of the HdAds cannot be accounted for by differences in particle content of the viral preparations because particle content was 1.8-fold higher in the HdAd vector preparation. The fact that helper-dependent vectors exhibit a significant improvement over first generation vectors suggests that the presence of the viral genome is a major factor contributing to vector-induced cytotoxic effects. It should be noted, however, that other factors must also contribute to such adverse affects as high titres of hdAds can also impair neuronal function.
In the absence of a viral genome the question remains as to the underlying cause of cellular toxicity observed with higher titres of hdAds. Helper virus contamination was unlikely to have been a contributing factor because the levels were relatively low at Ͼ1 p.f.u. per 10 5 b.f.u. One possibility is that the viral coat proteins themselves may induce cytotoxic effects, however, these effects are expected to occur in the short term. Alternatively, the stuffer DNA present in the fully deleted vector has been shown to affect vector performance. 46 For example, bacterial DNA has been shown to cause activation and induction of inflammatory genes in B lymphocytes and NK cells. [47] [48] [49] A comparison of helper-dependent Ads comprised of HPRT or lambda DNA stuffer fragments revealed that the HPRT DNA containing vector performed best. A possible reason suggested for the differences in the cellular response to foreign DNA was related to differences in DNA methylation and/or base composition. 46 The vector used in the present study contained HPRT stuffer DNA that performed best in the all assays tested, thus the marginal toxicity observed at higher titres may not be attributable to the stuffer DNA fragment. HdAds represent a major advancement over first generation vectors, however, there is room for even further improvement of such vectors.
Materials and methods
Preparation of adenovirus vectors
All cell culture supplies were obtained from Gibco/BRL, (Gaithersburg, MD, USA). The 293 cells and 293Cre4, cells that stably express Cre-recombinase, were grown in Dulbecco's MEM containing 5% fetal and 5% newborn bovine serum. The first generation adenovirus AdCA35, 50 was grown on monolayer cultures of 293 cells and purified on cesium chloride gradients as previously described. 51 The hdAd system using Cre-mediated excision of the helper virus packaging signal was previously described. Primary neuronal cell culture Primary cultures of cerebellar granule neurons were obtained from dissociated cerebella of postnatal day 8 or 9 mice, as previously described. 52, 53 with some modifications. Brains were removed and placed into separate dishes containing solution A (124 mm NaCl, 5.37 mm KCl, 1 mm NaH 2 PO 4 , 1.2 mm MgSO 4 , 14.5 mm d-(+)-glucose, 25 mm Hepes, 3 mg/ml BSA, pH 7.4) in which the cerebella were dissected, meninges removed and tissue sliced into small pieces. Tissue was briefly centrifuged and transferred to solution A containing 0.25 mg/ml trypsin, then incubated at 37°C for 18 min. Following the addition of 0.082 mg/ml trypsin inhibitor (Boehringer Mannheim Biochemicals, Indianapolis, IN, USA) and 0.25 mg/ml DNase I (Boehringer Mannheim) tissue was incubated at 25°C for 2 min. After a brief centrifugation, the resulting pellet was gently triturated in solution A yielding suspension that was further incubated for 10 min at 25°C in solution A containing 2.7 mm MgSO 4 and 0.03 mm CaCl 2 . Following a final centrifugation the pellet was resuspended in Eagle's minimum essential media (EMEM; Sigma, St Louis, MO, USA) containing 10% dialyzed fetal bovine serum (FBS; Sigma), 25 mm KCl, 2 mm glutamine (Gibco/BRL), 25 mm glucose, and 0.1 mg/ml gentamycin (Sigma) and filtered through a 70 m Falcon cell strainer (VWR Canlab, Ville MonteRoyal, QC, Canada). Cells were plated at a density of 1.5 × 10 6 cells per ml of medium on either Nunc four-well or 35 × 10 mm dishes (Gibco BRL) coated with poly-dlysine (Sigma). Adenovirus vectors were added to cell suspensions immediately before plating. To minimize non-neuronal cell contamination, cytosine ␤-arabinoside (10 m; Sigma) was added 24 h after plating yielding cultures comprised of 95% neurons.
Cell staining
Staining for expression of the ␤-galactosidase marker gene was performed for the times described in the figure legends. Cells were fixed with 0.2% glutaraldehyde in PBS (pH 7.4) for 15 min at 4°C. After two washes with PBS cells were incubated for 18 h in X-gal stain (2 mm MgCl 2 , 1 mg/ml X-gal, 5 mm K 3 Fe(CN) 6 , and 5 mm K 4 Fe(CN) 6 in PBS (pH 7.4). To estimate the percentage of cells that were infected, the total cell number and lacZpositive cells were counted in five random fields. The data were expressed as the average of three separate experiments with error bars representing the range. The number of cells counted was 250 to 300 cells per field.
[ -sensitive indicator fura-2 as previously described. 54 Five days following infection, neurons were loaded with fura-2 by incubating them for 30 min at 37°C in a normal buffer solution (NBS; 140 mm NaCl, 5 mm KCl, 1 mm CaCl 2 , 3 mm glucose, 30 mm glycine and 10 mm Hepes), containing 2.5 mm fura-2/AM. Experiments were conducted at room temperature on small groups of cells on glass coverslips in a custommade coverslip holder on the stage of a Zeiss IM inverted microscope (Carl Zeiss Canada, Don Mills, ON, Canada) coupled to a CM3 cation measurement spectrofluorimeter (Spex, Newark, NJ, USA). Measurements were performed using 350-and 380-nm excitation wavelengths alternating at a frequency of 1 Hz. The concentration of [Ca 2+ ] i was reflected in the ratio of the fluorescence intensities of fura-2 emission at 505 nm induced by the alternating excitation wavelengths. Figures shown are fluorometric tracings depicting the ratio of the fura-2 intensity at 505 nm following excitation of the cells at 350 and 380 nm. NMDA, kainate and AMPA were purchased from Research Biochemicals (Natick, MA, USA) and Fura-2-acetoxymethyl ester (fura-2/AM) was purchased from Molecular Probes (Eugene, OR, USA).
Total cellular protein synthesis assay Total protein synthesis was measured according to the protocols of Deckwerth and Johnson (1993) 55 and Easton et al. 15 Neurons were plated at a density of 1.5 × 10 6
Gene Therapy cells/ml in a 24-well Nunc dish. At the time of labelling cells were washed with PBS and 10 Ci
35
S-methionine (ICN Biomedicals, Irvine, CA, USA) in methionine, cysteine-free medium supplemented with 10 m methionine was added. After 4 h at 37°C cells were washed once with PBS and lysed with 500 l of 0.5% N-lauryl sarcosine, 1 mm EDTA, 10 mm Tris-HCl, pH 7.5. Protein was then precipitated on ice in 10% trichloroacetic acid (TCA) for 1 h and precipitable counts were collected by filtration and quantified by liquid scintillation counting. Results are expressed as percent of control (ie triplicate uninfected cultures) yielding total counts incorporated of 30 000-80 000 c.p.m. per culture.
Cell survival assays
To measure cell survival a quantitative MTT assay was used. Neurons were seeded in four-well Nunc tissue culture dishes and were infected with varying titres of either Ad(CA35) or hdAd(RP1050). At the times indicated on the figure legends cell survival was assessed using the colorimetric MTT survival assay (Cell Titer Kit; Promega, Madison, WI, USA) that measures the mitochondrial conversion of the tetrazolium salt to a blue formizan salt, used as previously described. 7 Results reported are the average of three separate experiments with variation expressed as standard deviation.
TUNEL staining
As an assay for cell death, TUNEL labelling was used to visualise cells with fragmented DNA. Cells were harvested 7 days after infection with AdCA35 or hdAd and fixed in 4% paraformaldehyde for 10 min followed by acetone/methanol (1:1) for 1 min. Cells were then washed in three changes of PBS and incubated for 1 h at 37°C with 75 l of a cocktail (Boehringer Mannheim) consisting of 0.5 l terminal transferase, 0.95 l biotin-16-dUTP, 6.0 l CoCl 2 , 15.0 l 5 × TdT buffer, and 52.55 l distilled water. Cells were then washed three times in PBS and incubated with a streptavidin Cy2 secondary antibody (Jackson Immunoresearch Laboratories, West Grove, PA, USA). Cells were counterstained with Hoechst 33258 and the fraction of TUNEL-positive cells was determined. The percentage of positive cells was quantified using a Zeiss Axiovert 100 fluorescent microscope (Carl Zeiss, Canada) equipped with Northern Eclipse software. A minimum of 500 cells was scored for each treatment and the data represent the mean of three independent experiments ± standard deviation.
